Short Interest in XOMA Co. (NASDAQ:XOMAP) Declines By 68.5%

XOMA Co. (NASDAQ:XOMAP) saw a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling 627 shares, a decline of 68.5% from the January 15th total of 1,989 shares. Based on an average trading volume of 737 shares, the short-interest ratio is presently 0.9 days. Based on an average trading volume of 737 shares, the short-interest ratio is presently 0.9 days.

XOMA Price Performance

Shares of XOMAP opened at $26.01 on Thursday. XOMA has a 1-year low of $24.96 and a 1-year high of $30.00. The firm has a 50 day simple moving average of $26.54 and a 200-day simple moving average of $26.37.

XOMA Company Profile

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.